EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic syndrome, genetic susceptibility, and risk of cardiovascular disease: a prospective study in the UK Biobank

Lin Zhu, Xijie Guo, Shuting Chen, Xin Fang, Chenyu Ni, Jiayu Zheng

Frontiers in Cardiovascular Medicine · 05.11.2026 · 13

DOI: 10.3389/fcvm.2026.1871387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 05.11.2026. Verfasst von Lin Zhu und 5 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

How metabolic syndrome (MetS) and genetic susceptibility jointly relate to cardiovascular disease (CVD) remains uncertain. We examined associations of MetS with incident CVD and evaluated their variation by polygenic risk score (PRS).

Methods

This prospective cohort study included 385,036 participants in the UK Biobank without CVD at recruitment. Cox regression models were used to estimate adjusted hazard ratios (HRs) for overall CVD, coronary heart disease (CHD), stroke, atrial fibrillation (AF), heart failure (HF), cardiovascular mortality, and all-cause mortality. We further evaluated the impact of specific MetS components and their cumulative burden on the risk for multiple CVD outcomes. Stratified analyses were conducted by sex and body mass index (BMI). Genetic predisposition was assessed by the PRS.

Results

During a median follow-up of 13.6 years, 61,129 incident CVD events, 5,585 CVD deaths, and 30,513 all-cause deaths were recorded. MetS was associated with incident CVD (HR 1.39, 95% CI 1.35–1.42), CHD (1.64, 1.59–1.69), stroke (1.38, 1.31–1.45), AF (1.14, 1.10–1.19), and HF (1.41, 1.33–1.49). It was also associated with CVD mortality (1.54, 1.42–1.67) and all-cause mortality (1.25, 1.21–1.30). Higher MetS component burden was associated with higher hazards of these outcomes. MetS associations with CVD were stronger in women (FDR-adjusted interaction P < 0.001), but did not differ significantly by BMI category ( P = 0.233). Exploratory HR-based RERI estimates were positive for CVD and CHD. Continuous PRSs were associated with CVD and CHD, but not HF.

Conclusion

MetS was associated with higher hazards of incident cardiovascular outcomes and mortality. Associations with incident CVD were stronger in women, whereas evidence of modification by BMI was limited. Genetic interaction findings were exploratory and require independent validation.

Zitieren

APA

Zhu, L., Guo, X., Chen, S., Fang, X., Ni, C., & Zheng, J. (2026). Metabolic syndrome, genetic susceptibility, and risk of cardiovascular disease: a prospective study in the UK Biobank. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1871387

Vancouver

Zhu L, Guo X, Chen S, Fang X, Ni C, Zheng J. Metabolic syndrome, genetic susceptibility, and risk of cardiovascular disease: a prospective study in the UK Biobank. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1871387

BibTeX
@article{Zhu2026,
  author = {Zhu, Lin and Guo, Xijie and Chen, Shuting and Fang, Xin and Ni, Chenyu and Zheng, Jiayu},
  title = {Metabolic syndrome, genetic susceptibility, and risk of cardiovascular disease: a prospective study in the UK Biobank},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1871387}
}
Kostenlos starten →